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Under proper conditions, whole blood can be stored at room temperature for as long as 21 days before measurement of glycosylated hemoglobin by affinity chromatography. Whole blood (anticoagulated with EDTA or heparin) was placed in capillary tubes, which were then sealed at both ends and stored at room temperature. Just before assay, whole blood was nnsed from the tubes and diluted 10-fold with water. Samples of each patient's blood were assayed as wholeblood hemolysates by affinity chromatography after zero, seven, 14, and 21 days of storage. Values for glycosylated hemoglobin did not change over 21 days of storage and values for each storage day correlated well (r = 0.97, p < .0001) with hemoglobin Aic measured in fresh erythrocyte hemolysates by "high-performance" liquid ion-exchange chromatography.
Addftlonal Keyphrases: screening diabetes
Glycosylated hemoglobin is now widely measured as an index of long-term glycemic control in diabetic patients (1).
We recently reported the use of m-aminophenylboronic acid affinity chromatography to measure glycosylated hemoglobin (2) . This method has certain important advantages for the clinical laboratory over previously described techniques in that it is relatively insensitive to changes in temperature and is not affected by labile hemoglobin fractions (2) tare,but with increases in values thereafter. In that study, erythrocytes from stored whole blood were washed and incubated before assay. In this report, we show that whole blood hemolysates prepared before assay, without washing or incubation of erythrocytes,
show stability for at least 21 days. We also give data on a micro-scale method for blood sample collection that is well suited to this affinity method.
Materials and Methods
We obtained blood specimens from 34 diabetic and nondiabetic subjects by venipuncture and collection in EDTAcontaining tubes. Part of each specimen was transferred to four Caraway capillary tubes (300-350 L capacity), which were then sealed with putty sealant (Critoseal; American Scientific, St. Louis, MO 63043)on one end and Parafllm on both ends. Three of the capillary tubes were then stored at room temperature (20-24 #{176}C) until assayed seven, 14, and 21 days later. The fourth capillary tube from each subject was assayed by affinity chromatography on the same day the blood was collected. Nine of the 34 specimens collected in EDTA were also collected in heparinized tubes. Five additional specimens of capillary blood were collected via finger-stick directly into standard heparinized microhematocrit capillary tubes. These capillary tubes were then sealed at both ends with plastic caps (Critocaps, American Scientific).
To determine the effects of glucose on affinity chromatography results before and after storage of whole blood, some samples were supplemented with glucose to give final plasma glucose concentrations ranging from 0.93 to 13.6 g/ L. An aliquot of each sample was then assayed and the remaining samples were stored at room temperature in capillary tubes until assay seven and 14 days after collection. Just before assay, whole blood was washed from the capillary tubes with water and finally diluted about 10-fold. Glycosylated hemoglobin was measured with the Glycosylated Hemoglobin Clinovative Diagnostic Kit (Pierce Chemical Co., Rockford, IL 61105). Fifty microliters of the diluted hemolysate was applied directly onto each column, and each sample was assayed in duplicate according to instructions provided in the kit. For quality control, pooled hemolysates stored at -70 #{176}C from diabetic and non-diabetic subjects were assayed with each batch of samples.
For comparison with affinity chromatography results, we used an aliquot of each fresh whole-blood sample to prepare an erythrocyte hemolysate for analysis for hemoglobin A1 by a semi-automated "high-performance" liquid-chromatographic ion-exchange method (3). These hemolysates were stored at -70 #{176}C until analysis.
Results
Values for glycosylated hemoglobin in diabetic and nondiabetic samples stored as whole blood in capillary tubes showed no appreciable change in glycosylated hemoglobin after 21 days at room temperature. The mean glycosylated hemoglobin values (± SEM) of 34 whole-blood samples were 13.45 ± 0.59, 13.62 ± 0.60, 13.30 ± 0.58, and 13.22 ± 0.61 on days zero, seven, 14, and 21, respectively. None of the differences is significant. Figure 1 shows the relationship between individual glycosylated hemoglobin values obtained on day 21 vs day 0. The regression line (y = 1.03x -0.50) falls very close to the unity line and individual variability around these lines is relatively small. The average coefficient of variation between stored whole-blood samples assayed on different days was 3%. The inter-assay CVs for the pooled diabetic and non-diabetic hemolysates were 3.05% and 2.59%, respectively. There were also no significant differences in glycosylated hemoglobin values between paired EDTA-treated and heparinized blood samples stored for 21 days. Glycosylated hemoglobin as measured by affinity chromatography on each of the storage days correlated strongly with hemoglobin A1 measured in fresh hemolysates by ionexchange chromatography, an established method (y = 1.53x -0.996, all r values = 0.97, p < .0001).
Results by the affinity chromatography method do not appear to be affected directly by variations in glucose concentration in the range we studied. However, after storage at room temperature for 14 days, blood samples with plasma glucose values greater than 6.72 g/L showed significant increases in glycosylated hemoglobin (Table 1) .
Discussion
Many techniques are available for measuring glycosylated hemoglobin. For the clinical laboratory, the choice of a method can be very difficult. Important considerations in selecting an appropriate method include its accuracy, equipment costs, extent of interference by labile fractions, and temperature and pH sensitivity. Other important considerations include convenience of sample collection, sample storage stability, and assay speed (4).
We and others have shown that sample storage conditions and sample preparation before assay are critical for most assay techniques. For ion-exchange and electrophoretic methods, it is necessary to remove the labile fraction (pro-A1) which co-chromatographs or co-migrates with the stable glycosylated hemoglobin (3, 5) . Ion-exchange and electrophoretic results are also affected by artifactual increases in the hemoglobin A10+bfraction during storage of whole blood or hemolysates at room temperature (3, 6) . Analysis for glycosylated hemoglobin by the thiobarbituric acid colorimetric method requires that glucose be completely removed before assay (4) .
Affinity chromatography is technically simple and is not significantly affected by the above factors. Our results show that it is feasible to measure glycosylated hemoglobin by affinity chromatography in whole blood collected in capillary tubes and stored at room temperature for long intervals without removing glucose or labile glycosylated hemoglobin before assay. As little as 10 L of whole blood collected by finger stick suffices for assay in duplicate, and either EDTA or heparin can be used as an anticoagulant. The method is easily adaptable to large-volume batch assays, the average assay time being about 6 mm per duplicate sample. Results are not affected appreciably by sample glucose concentration unless it exceeds 6.7 g/L. One important technical consideration is that samples not be allowed to dry during storage to avoid in vitro protein glycosylation with spuriously increased test results (7) . Furthermore, for storage at room temperature, stability is greatest when hemolysates are prepared directly from whole blood, without washing the erythrocytes or incubation with saline before assay. With this assay method, the ease of sample collection and the storage stability of samples have important clinical applications aside from the direct advantages for the clinical laboratory. This method may be particularly well suited to large diabetic screening studies and as an adjunct to routine diabetes care where patients are carrying out home monitoring of capillary blood glucose. In this situation, patients could collect whole-blood samples at home and send them directly to the central laboratory.
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